Itxaso del Palacio
Teaching Fellow in Entrepreneurship, FHEA @ University College London (UCL)
London, United Kingdom
Itxaso del Palacio is a Partner at Notion, a leading European B2B SaaS focused VC which has invested in companies such as GoCardless, CurrencyCloud, TradeShift and Unbabel among others. Prior to that, she Itxaso was the Investment Partner for M12 (formerly Microsoft Ventures) in Europe. Some of the most recent investments led by Itxaso include MyaSystems (conversational AI for recruiting), ForestAdmin (admin panel framework), Yulife (new life insurance provider), Onfido (identity verification platform), Unbabel (Machine Translation solution) and Beamery (CRM of recruitment). On the academic side, Itxaso is a Senior Teaching Fellow in Entrepreneurship at UCL School of Management. For the past nine years, Itxaso has taught entrepreneurship at UCL, Imperial College and the Royal College of Arts in London. She is passionate about helping entrepreneurs at universities building their businesses. Itxaso holds a prestigious Kauffman Fellowship and is very well connected to the global network of fellow investors. By background, Itxaso is an engineer and has a PhD in entrepreneurship and venture capital.
- Total investments:
- 22
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Itxaso del Palacio invests in
Stages Itxaso del Palacio invests in
Countries Itxaso del Palacio invests in
Investment Focus
Industry
- Software 6 (27%)
- Information Technology 5 (23%)
- FinTech 2 (9%)
- Insurance 2 (9%)
- Recruiting 2 (9%)
Stage
- Seed 5 (23%)
- Series B 5 (23%)
- Series A 4 (18%)
- Series C 2 (9%)
- Series D 1 (5%)
Country
- United Kingdom 7 (32%)
- France 2 (9%)
- Spain 1 (5%)
- Belgium 1 (5%)
- Germany 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OpenTrade
|
OpenTrade gives Web3 treasurers and institutional investors access to on-chain structured financial products backed by investment grade financial assets, resulting in predictable returns that are uncorrelated with cryptocurrency. | $17M / Venture - Series Unknown / May 06, 2026 | |
Naboo
|
Give your teams the freedom to meet where they want, when they need | $70M / Series B / Feb 09, 2026 | |
GoodFit
|
At GoodFit, we help our customers unlock their next stages of growth with highly actionable & relevant data. Without a need to spend thousands of hours on manual research, B2B companies use GoodFit's data engine to identify their next opportunities, understand their customers & generate demand.Our platform takes data from hundreds ofsources across the internet, and combines it into a real-time and constantly updated view of each opportunity our clients monitor. We process a lot of data to do this, and utilise best-in-class data processing technologies to do this at scale, robustly and efficiently. | $13M / Series A / Sep 29, 2025 | |
Tern Group
|
Tern Group is an AI Platform to hire and relocate top healthcare talents globally, faster and cheaper. TERN is a full-stack solution to source and relocate top-tier medical and engineering talent from India, North Africa, South Africa, and Central Asia and the approach ensures a seamless, ethical, and transparent migration process, drasticallycutting complexity and shaving costs for healthcare systems. | $24M / Series A / Sep 10, 2025 | |
Orus
|
Orus provides simple and transparent insurance coverage. The company is on a mission to offer simple, affordable, and tailored insurance coverage to European SMBs to give them the peace of mind to focus on what matters. | $29M / Series B / Jun 24, 2025 | |
|
OpenTrade
|
OpenTrade gives Web3 treasurers and institutional investors access to on-chain structured financial products backed by investment grade financial assets, resulting in predictable returns that are uncorrelated with cryptocurrency. | $7M / Seed / Jun 11, 2025 | |
|
Naboo
|
Give your teams the freedom to meet where they want, when they need | $20.9M / Series A / Jan 28, 2025 | |
Nelly
|
Nelly provides a tool for medical practices that simplifies patient onboarding and payments. It creates the basis for stress-free and clear work in your practice by drastically reducing the administrative effort for doctors, MFAs, ZFAs, and patients with Nelly. 90% of all healthcare professionals perceive bureaucracy and administrative burdens asthe biggest problem in the workplace.The company's mission is to reduce the administrative effort in the healthcare sector by simplifying documentation and payment processes in order to make the practice visit more patient- and employee-friendly. | $51.5M / Series B / Jan 14, 2025 | |
|
Orus
|
Orus provides simple and transparent insurance coverage. The company is on a mission to offer simple, affordable, and tailored insurance coverage to European SMBs to give them the peace of mind to focus on what matters. | $11.7M / Series A / Oct 10, 2023 | |
Fertifa
|
Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom. | $6.3M / Seed / Jun 30, 2023 | |
| See all 22 investments → | |||
Co-Investors
About University College London (UCL)
UCL was established in 1826 to open up education in England for the first time to students of any race, class or religion. UCL was also the first university to welcome female students on equal terms with men. Academic excellence and conducting research that addresses real-world problems inform our ethos to this day.
University College London (UCL) Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Keith Willey
Faculty Department of Management Science and Innovation
|
|||
Andrew Hudson-Smith
Director, Centre for Advanced Spatial Analysis
|
|||
Chris Mason
Professor of Cell & Gene Therapy
|
|||
Christian Nold
Researcher
|
|||
Damian Crowther
Honorary Associate Professor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Itxaso del Palacio invest in?
Itxaso del Palacio invests primarily in Software, Information Technology and FinTech startups, most often at Seed and Series B stage. Most of the 22 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Itxaso del Palacio last invest?
The most recent investment recorded for Itxaso del Palacio closed in May 2026. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
